Adamas Pharmaceuticals, Inc.: cashflow_investing

Value{"amount": -5973000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2020-01-01 – 2020-06-30
Statuscurrent
EntityAdamas Pharmaceuticals, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001328143-20-000042 · Open the official SEC filing →
Retrieved: 2026-08-19T12:42:20.451056+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001328143/cashflow-investing/2020-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/6059eade-a578-4eb8-a1cd-edf87d0b9c2f

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies